AV Hysteresis Circuit with Dynamic PVARP for PMT Avoidance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable cardiac devices face challenges in preventing pacemaker-mediated tachycardia (PMT) and other arrhythmic heart rhythms during AV hysteresis, as standard programmable post-ventricular atrial refractory periods (PVARP) are not always effective in avoiding PMT and can lead to rhythms like repetitive non-reentrant ventriculo-atrial synchronous (RNRVAS) and AV nodal reentrant tachycardia (AVNRT).
Innovation Solution
An implantable cardiac stimulation system with an AV hysteresis circuit that extends the AV interval and a refractory circuit that establishes a lengthened PVARP, which senses retrograde P waves to restore the AV interval and PVARP to their base values, and includes an arrhythmia detector for corrective therapy to manage arrhythmic rhythms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard PVARP is used during AV hysteresis, then device complexity is minimized, but PMT prevention reliability is insufficient
Solution Approach 1:
The patent implements a dynamic PVARP that automatically adjusts its duration based on the AV interval setting. When AV hysteresis is active (extended AV interval), the PVARP is automatically lengthened to prevent PMT. This dynamic adjustment resolves the contradiction by providing enhanced PMT prevention reliability only when needed, without permanently increasing device complexity.
Solution Approach 2:
The patent changes the PVARP parameter dynamically based on the AV interval configuration. By linking PVARP duration to the AV interval state (base vs. extended), the system adapts the refractory period to match the current operating mode, ensuring reliable PMT prevention during AV hysteresis while maintaining simpler operation during standard pacing.
2Reliability
If AV interval is extended to promote intrinsic conduction, then intrinsic heart activity is improved, but arrhythmia risk increases
Solution Approach 1:
The patent applies preliminary anti-action by establishing a lengthened PVARP before arrhythmias can develop. When the AV interval is extended to promote intrinsic conduction, the system proactively lengthens the PVARP to block potential retrograde conduction pathways before they can initiate PMT or other arrhythmias, thus preventing harmful effects before they occur.
Solution Approach 2:
The lengthened PVARP acts as an intermediary protective mechanism between the extended AV interval and the heart tissue. It mediates the potential harmful effect of AV hysteresis by providing an additional refractory barrier that prevents retrograde atrial impulses from triggering ventricular pacing, thereby allowing AV interval extension while blocking arrhythmia development.
3Reliability
If PVARP is lengthened to prevent PMT, then PMT avoidance is improved, but RNRVAS and AVNRT prevention becomes insufficient
Solution Approach 1:
The patent implements dynamic adjustment of the atrial escape interval that complements the lengthened PVARP. When retrograde P waves are detected during the extended PVARP, the system dynamically modifies the atrial escape interval to prevent RNRVAS. This dynamic response resolves the contradiction by providing targeted protection against different arrhythmia mechanisms based on real-time sensed events.
Solution Approach 2:
The patent employs feedback mechanisms where the detection of retrograde P waves during the extended PVARP triggers specific responses. The sensing of these retrograde impulses provides feedback that activates corrective actions (such as adjusting the atrial escape interval or inhibiting further pacing), thereby preventing RNRVAS and AVNRT while maintaining PMT protection.
Data Source
AI summary
An implantable cardiac stimulation device provides AV interval hysteresis to promote intrinsic conduction while providing PMT avoidance. The device comprises a pulse generator that provides atrial and ventricular pacing stimulation pulses on demand separated by an AV interval, an AV hysteresis circuit that extends the AV interval from a base AV interval to an extended AV interval to promote intrinsic heart activity, and a refractory circuit that establishes a PVARP following each provided ventricular pacing pulse including a lengthened PVARP longer in duration than a normal PVARP responsive to the AV hysteresis circuit extending the AV interval from the base AV interval to the extended AV interval.